Catalys Pacific, LLC — Q2 2025 13F-HR

← Catalys Pacific, LLC

Q2 2025 · 13F-HR

Catalys Pacific, LLCholdings as filed

Filed 2025-08-13 · accession 0001104659-25-077546

$131.7M

Reported value

Positions

2025-06-30

Period end

View analyzed profile →PRO

Holdings as filed

CUSIP	Ticker	Issuer	Value	% port.	Shares	Class	Voting
603170101	MLYS	Mineralys Therapeutics, Inc.	$120.5M	91.5%	8,903,838	Common	SOLE
71722W107	PHAT	Phathom Pharmaceuticals, Inc.	$11.2M	8.50%	1,167,114	Common	SOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.